Oncology Trials Update | Applied Clinical Trials:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Unsubscribe from this list.
Oncology Trials Update

Applied Clinical Trials

Click here to search FindPharma.com
FindPharma
TOP SEARCHES: December Issue // FDA 1572 // Key Factors in CRO Selection
Oncologists Up on Research
Oncology Study Results
Q&A with Lilly
Medpace Buys Oncology CRO
Quintiles’ Phase II Deal
Key Topic Updates


BIO Annual Convention
May 3-6, Chicago

ASCO
June 4-8, Chicago

LCGC Europe - News Update
Avon Helps with Breast Cancer
Inside Outsourcing
Participate in Global Site Survey
Contact Us
Contact Lisa Henderson, Editor-in-Chief.

Learn about direct mail opportunities.

Learn about advertising opportunities.

Learn about reprints of Applied Clinical Trials.
February 4, 2010
Oncologists Optimistic on Future of Clinical Trials
A survey from U.S. Oncology uncovered the real view that oncologists and clinical research professionals have about the current state of the clinical trial market. While the overall mood is optimistic, many believe that the lengthy clinical trial approval process is one that needs to be addressed. More...
Clinical Trials Results
Applied Clinical Trials’ own summary on the latest developments in Phase I through IV in oncology. More...
Lilly’s Paul Talks Oncology
Steven Paul, president of Lilly Research, speaks to Pharmaceutical Executive editor George Koroneos about its new development plan, which includes 21 molecules in oncology. More...
Medpace Gains in Oncology
Medpace acquired Pharma Brains AG, an oncology-focused CRO based in Basel, Switzerland. More...
Quintiles and Eisai on Phase II
Quintiles entered into a strategic alliance with Eisai to develop six potential oncology compounds in its pipeline, specifically in Phase II proof-of-concept.   More...
Key Topic Updates
Clinical Trials
Trials Where They Make Sense
Market Overview
Oncology Market Outlook
Oncology Session Overview
Imaging
Optimize Imaging
Imaging as Biomarkers
On and Offsite Image Reads
Imaging Biomarker Network
 
You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.

To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this,
click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.